The Moscow Department for Investment and Industrial Policy, together with the Moscow City Investment Agency, presents the new issue of the monthly Moscow Investment Digest.

Main topics:

  • Russian and Foreign Business Continues to Invest in Moscow
  • Moscow Got New Oncologic Center Under the Concession Agreement
  • Investor Will Put RUR 2.8 Bn in Construction of New Pharmaceutical Plant in Moscow
  • Business Activity in Moscow Reached Pre-Crisis Level
  • 246 Premises in Moscow Can Be Rented at a Reduced Rate

The full version of the Moscow Investment Digest, as well as an archive of past issues, is available at the Press Center of the Moscow Investment Portal.

On the Moscow Investment Portal, you may also subscribe to our monthly digest to your specified email address.

RELATED MATERIALS

In more detail
13 Aug
Moscow Increased Subsidy Opportunities for Exporters
In more detail
12 Aug
Production of Artificial Lung Ventilation Training Simulators Launched in Technopolis Moscow SEZ
In more detail
10 Aug
Project of Rudnevo Industrial Zone Re-Development Approved
Vladimir Yefimov: Moscow budget will give RUR 60 bn to the affected business
Gen Terra
The Kalibr Technopark in Moscow accommodates the only Russian industrial manufacturer of chemicals for molecular biology. In his interview to the Moscow Investment Portal, Gen Terra director Vladimir Survilo talked about DNA, genome sequencing and plans to conquer the international market.
Moscow Pharmaceutical Factory
The history of the Moscow Pharmaceutical Factory began in the 1930s. Moscow had a fast-growing demand for medications and pharmacies were cropping up. Mostly, factories produced “galenic” medications (tinctures, extracts, and drops based thereon) derived from medicinal plants: motherwort, valerian root, calendula, eleuthero, etc.
All topics